Newsletter
China Patent Linkage to Land Soon -- “Implementing Measures for a Pharmaceutical Patent Dispute Early Resolution Mechanism (Trial for Implementation) (Draft for Public Opinions)”
China Patent Linkage to Land Soon –
“Implementing Measures for a Pharmaceutical Patent Dispute Early Resolution Mechanism (Trial for Implementation) (Draft for Public Opinions)”
The National Medical Products Administration (NMPA) and the China National Intellectual Property Administration (CNIPA) issued the draft “Implementing Measures for a Pharmaceutical Patent Dispute Early Resolution Mechanism (Trial for Implementation) (Draft for Public Opinions)” (the "Draft Measures") on 11 September 2020 (https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/zhqyj/zhqyjyp/20200911175627186.html). With the release of Draft Measures, it can be considered that the concepts regarding patent linkage system in 2017 have become both concretized and practical. In other words, the patent linkage system in China is within reach, and the system can be expected to land eventually. Please refer to the attachment for detailed report.
-
附件下載
-
格式